99久久精品国产一区_国产欧美日韩综合视频_日本黄色影片在线观看_黄页视频在线网站_国产亚洲欧美日本在线_色五月激情五月亚洲综合考虑_黄色三级毛片久久免费_真人三级片播九公社_成版人黄漫免费网站_精品中文自拍亚洲

Your Position: Home > News > Industry News

Mesenchymal stem cells (MSCs) are expected to be one of

2019/11/19??????view:
[Chinese pharmaceutical industry] dynamic mesenchymal stem cells exist in all tissues, including from neonatal perinatal tissues (placenta) mesenchymal stem cells compared to other sources of more pure and more primitive, regulation has stronger ability of proliferation and differentiation and immune cells. At present, the stem cell technology has been listed as a strategic and forward-looking scientific special project in China, and it is expected to achieve a major breakthrough in the future and seize the commanding heights of the world science.
(human umbilical cord mesenchymal stem cells derived from stem cells among pictures)
In recent years, artificial intelligence, virtual reality, big data, biomedicine and other industries have attracted widespread attention. Among them, stem cell and regenerative medicine are the most explosive branches in the field of biomedicine.
Mesenchymal stem cells in vivo and in vitro specific, can differentiate into adipose tissue, bone, cartilage, muscle, tendon, ligament, nerves, liver, myocardium and endothelial cells, cultured and cryopreserved still have the potential of multi-directional differentiation, can be used as ideal seed cells for tissue and organ repair caused by aging and disease, the research has been applied to the treatment of liver cirrhosis, diabetes, neurodegenerative disease, nerve injury, Alzheimer's disease and diseases such as lupus erythematosus.
With the world's most authoritative stem cell database, the National Institutes of Sciences Database, nearly 6000 studies of stem cells have been registered worldwide, of which 80% are mesenchymal stem cell transplantation studies. For example, Gary Steinberg, professor and Department of Neurosurgery director at the Stanford University School of medicine, conducted a clinical study of mesenchymal stem cell therapy for stroke. A total of 379 patients with ischemic stroke were treated with injections of mesenchymal stem cells for clinical studies. The researchers monitored the effect of mesenchymal stem cells on blood pressure, clinical assessment, and brain imaging. The study found that the patient's motor performance index improved significantly over a month and remained for 6 months to 1 years. The study again demonstrates the value of mesenchymal stem cells in medical research.
As of now, the State Planning Commission filing a total of 15 stem cell clinical research projects, including 10 projects with mesenchymal stem cells, it also represents the mesenchymal stem cell application has become the mainstream of the future, will usher in the outbreak stage of clinical research.
Mesenchymal stem cells exist in all tissues, including from neonatal perinatal tissues (placenta) mesenchymal stem cells compared to other sources of more pure and more primitive, regulation has stronger ability of proliferation and differentiation and immune cells. With the development of technology of frozen stem cells, we have now been able to isolate mesenchymal stem cells from umbilical cord, placenta, in deep hypothermia environment for a long time "frozen", extract used in our future or relatives suffered a stroke and other diseases, to prevent disease in the bud.
China has nearly 100 different scale stem cell companies to provide such services, but to ensure long-term and high activity of stem cell preservation, there are still high barriers to cost, safety and preparation technology. But stem cells adhering to the guidelines of production, study and research combining, combined with Hong Kong University Science & Technology, Tongji University and the Shanghai's top research institutions break through technical barriers, in Jiangsu, Guangdong, Zhejiang has established the international standard cell library automation, supporting laboratory and regional cell preparation center, provide high quality variety the type of cell storage service for the public, is committed to the neonatal perinatal tissue stem cell collection, preparation, storage and clinical translational research.
It is worth mentioning that, stem cell technology has been listed as China's strategic, forward-looking major scientific special, the future is expected to achieve a major breakthrough, to seize the commanding heights of the world science.
In China's economic development strategy, the stem cell industry and regenerative medicine have been entrusted with an important mission. With the development of stem cell technology, mesenchymal stem cells (MSCs) will become one of the most advanced methods in medicine and surgery.